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Zombie cells
 
ooks can be deceiving—even a cell that appears healthy may be 
doomed to die. Ekert et al. (page 835) report that cells lacking two
important caspases can survive in the short term without a growth factor, 
but will succumb eventually. Thus, the normal job of these caspases may 
be to accelerate the dying process rather than control the commitment of 
cells to death.
The situation varies between organisms. In worms, deletion of CED-4 
and CED-3 (the homologues of mammalian Apaf-1 and caspase-9) completely 
prevents programmed cell death. Some mice without Apaf-1 and caspase-9 
die from neuronal overgrowth but others fare just fine. One possibility is 
that another caspase such as caspase-2 takes over when caspase-9 is absent 
or can’t be activated by Apaf-1.
L
The death of cells lacking some caspases is 
delayed but still inevitable.
 
Ekert and colleagues used growth factor–dependent cell lines to study apoptosis when Apaf-1, caspase-9, or caspase-9 
and -2 were missing. When deprived of the factor IL-3, none of the cells shrank, had blebbed membranes, or exhibited 
any other obvious apoptotic phenotypes. But closer examination revealed that, though normal to the naked eye, the cells 
had released cytochrome 
 
c
 
 from their mitochondria—a classic sign of apoptosis. To add insult to injury, the cells were 
essentially zombies. Even when IL-3 was restored to the medium they could not make clones. Marsden et al. (page 775) 
similarly find that lymphocytes and fibroblasts lacking caspase-2 and -9 remained sensitive to many apoptotic stimuli.
The cause of cell death in the caspase-deleted cells remains unclear. Mitochondrial ATP generation may be fatally 
compromised by the leakage of cytochrome 
 
c
 
, another mitochondrial factor may leak out, or another caspase may initiate 
an irreversible event. Whatever the explanation, the current results suggest that the loss of certain caspases in cancer cells 
does not necessarily explain the increased survival of these cancer cells. 
 
 
 
Actin gets Hip at the TGN
 
thick mess of cortical actin works intimately with clathrin to assist 
endocytosis at the plasma membrane, with the actin providing 
force for vesicle fission, propulsion, or both. Now, Carreno et al. 
(page 781) show that the less well-known actin around the trans-
Golgi network (TGN) also aids in the trafficking of clathrin-coated 
vesicles from TGN to lysosomes.
The clue for such a link came from studies of Hip1R, a protein 
that links actin to clathrin-coated endocytic vesicles. When the 
team knocked down Hip1R expression using RNAi, they found 
abnormally swollen Golgi cisternae with many extra buds or vesicles 
stuck to the surface of the TGN. Subsequent fluorescent phalloidin 
staining of Hip1R-depleted cells also revealed abnormal actin 
formations at the Golgi surface. Similar actin-based curved struc-
tures have also been found when Hip1R is missing from budding 
sites for clathrin-coated vesicles at the plasma membrane. These 
parallels suggest that actin is involved in a general clathrin-coated 
vesicular budding mechanism.
The vesicles coming from the TGN contain the Arp2/3 complex 
as well as the mannose-6-phosphate receptor that targets proteins 
to the lysosome. Both depletion of Hip1R and treatment of cells 
with actin poisons halted proper trafficking of a lysosomal hydrolase, 
showing that these actin-dependent vesicles were traveling from 
A 
Actin (red) is involved in budding of clathrin-coated vesicles from 
the TGN (green).
 
the TGN to the lysosome. This new function for actin, along with the proximity of the Arp2/3 complex on these vesicles, raises 
the possibility that the intracellular pathogen 
 
Listeria monocytogenes
 
 could co-opt vesicle trafficking machinery rather than general 
cell cytoskeletal components for its movement.
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